Skip to Main Content

File this under “Half a loaf.”

A long-awaited move by the pharmaceutical industry to offer more transparency into its practices appears to have backfired in Canada, where newly disclosed payments to doctors and hospitals is sparking criticism and calls for mandatory reporting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!